Search Medical Condition
Please enter condition
Please choose location

Semarang, Indonesia Clinical Trials

A listing of Semarang, Indonesia clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

PCOS Treatment Using DLBS3233 Metformin and Combination of Both

There will be 3 groups of treatment (N = 186), each consist of 62 subjects, as the following: Treatment I : DLBS3233 100 mg once daily Treatment II : Metformin XR 750 mg twice daily Treatment III : DLBS3233 100 mg once daily and Metformin XR 750 mg twice daily. ...

Phase

0.0 miles

Learn More »

DLBS1033 for Acute Ischemic Stroke Patients

Subjects in this study will be screened consecutively and eligible subjects will be randomized into two groups and receive the investigational drug, DLBS1033 at a dose of 490 mg three times daily or its placebo in addition to standard therapy for 28-days course of therapy. Standard therapy used in this ...

Phase

0.0 miles

Learn More »

Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)

Background: Existing criteria for AS/SpA such as mod. New York, ESSG, or Amor criteria for classification and/or diagnosis of spondyloarthritis have limitations when applied to early disease. Moreover, MRI is not part of any of the established criteria and the precise role of MRI in early axial disease has not ...

Phase N/A

1.19 miles

Learn More »

Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests (RDTs) Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients to Improve Clinical Management in Indonesia.

This study will collect demographic data, medical history, clinical data, treatment, and risk factors of pneumonia. The study also record the supporting examination results include but not limited to Complete Blood Count (CBC) results, blood gas analyses result, CRP, PCT, culture result, rapid test for influenza, Respiratory Syncytial Virus (RSV), ...

Phase N/A

8.12 miles

Learn More »

Tuberculosis Research of INA-RESPOND On Drug Resistance

This study is a prospective observational cohort study of TB patients who are treated or evaluated at 10 study sites. Patients presenting with cough for 2 weeks or longer with at least one additional TB symptom and a chest X-ray suggestive of TB, will be invited to be enrolled in ...

Phase N/A

8.12 miles

Learn More »